Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
708.00Today’s High
730.2052W low
296.6052W High
794.50Open Price
720.00Prev. Close
664.6000Volume
44220.00Value
31429365.00Fundamentals
Market Cap Cr
1485.50
Price to Earnings
25.50
Price to Book Value
3.30
Dividend Yield
0.60
PE to Growth
0.70
Op Revenue TTM Cr
630.96
Net Profit TTM Cr
58.19
Cash From Operating Activity Cr
108.96
Return on Equity %
12.93
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
57.5
Week
53.6
Month
50
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
716.32
PIVOT
First Resistance
724.63
Second Resistance
738.52
Third Resistance
746.83
First Support
702.43
Second Support
694.12
Third Support
680.23
Relative Strength Index
58.71
Money Flow Index
44.77
MACD
27.37
MACD Signal
31.08
Average True Range
29.09
Average Directional Index
30.99
Rate of Change (21)
18.64
Rate of Change (125)
34.65
Commodity Channel Index
32.5
Williams %R
-61.8
BETA
1 Month
0.96
3 Month
0.87
1 Year
0.73
3 Year
PRICE CHANGE ANALYSIS
↑ 0.43%
1 Week
Low
High
690.05
750.95
↑ 12.58%
1 Month
Low
High
555.05
794.5
↑ 27.21%
3 Months
Low
High
495.65
794.5
↑ 40.22%
6 Months
Low
High
452.55
794.5
↑ 140%
1 Year
Low
High
296.6
794.5
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 175.72 | 165.38 | 155.91 | 147.41 | 143.05 | 121.87 | 135.34 | 122.79 | 125.14 | 119.38 | 116.47 | |
| Operating Expenses Qtr | 149.35 | 141.88 | 133.99 | 127.64 | 124.27 | 105.75 | 116.67 | 106.14 | 107.85 | 104.55 | 102.10 | |
| Operating Profit Qtr | 21.93 | 20.34 | 18.69 | 17.14 | 16.44 | 13.95 | 16.06 | 13.79 | 14.29 | 13.04 | 13.15 | |
| EBIDT Qtr Cr | 26.38 | 23.50 | 21.93 | 19.77 | 18.78 | 16.11 | 18.67 | 16.65 | 17.29 | 14.84 | 14.37 | |
| Depreciation Qtr | 3.54 | 3.39 | 3.33 | 3.19 | 3.57 | 3.13 | 2.90 | 2.76 | 2.90 | 3.15 | 3.08 | |
| Net Profit Qtr | 16.95 | 15.10 | 14.03 | 12.07 | 11.45 | 9.19 | 12.21 | 9.80 | 15.23 | 8.31 | 8.30 | |
| Basic EPS Qtr | 8.15 | 7.26 | 6.75 | 5.79 | 5.37 | 4.24 | 5.60 | 4.50 | 7.19 | 4.14 | 4.11 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 644.42 | 523.05 | 472.64 | 430.70 | 329.81 | |
| Operating Expenses Annual Cr | 552.85 | 452.84 | 413.04 | 372.91 | 288.18 | |
| Operating Profit Annual | 78.10 | 60.24 | 52.90 | 54.69 | 40.67 | |
| Operating Profit Margin Annual % | 12.12 | 11.52 | 11.19 | 12.70 | 12.33 | |
| Total Expenses Annual Cr | 567.40 | 465.99 | 426.60 | 387.17 | 299.24 | |
| EBIDT Annual Cr | 91.57 | 70.21 | 59.60 | 57.79 | 41.63 | |
| EBIDT Annual margin % | 14.21 | 13.42 | 12.61 | 13.42 | 12.62 | |
| Depreciation | 13.44 | 12.36 | 12.15 | 12.96 | 8.69 | |
| PAT Before ExtraOrdinary Items Annual Cr | 58.14 | 42.64 | 38.56 | 5.01 | 22.46 | |
| Net Profit Annual | 58.14 | 42.64 | 38.56 | 5.01 | 22.46 | |
| Basic EPS Annual | 27.95 | 19.71 | 18.81 | 2.75 | 35.03 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 450.29 | 402.67 | 395.13 | 198.99 | 216.48 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 4.52 | 5.46 | 2.25 | 3.58 | 2.41 | |
| Total Current Liabilities Annual Cr | 171.35 | 120.88 | 93.65 | 93.42 | 124.92 | |
| Total Capital Plus Liabilities Annual Cr | 626.16 | 529.01 | 491.03 | 295.99 | 343.80 | |
| Fixed Assets Annual | 184.76 | 124.19 | 99.20 | 95.98 | 68.43 | |
| Total Non Current Assets Annual | 194.92 | 175.47 | 109.39 | 101.84 | 181.14 | |
| Total Current Assets Annual | 431.24 | 353.54 | 381.63 | 194.16 | 162.66 | |
| Total Assets Annual | 626.16 | 529.01 | 491.03 | 295.99 | 343.80 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 14.11 | 3.25 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 108.91 | 60.98 | 9.00 | 11.45 | 20.88 | |
| Cash from Investing Activity Annual | -92.07 | -14.11 | -154.31 | -20.19 | -9.17 | |
| Cash from Financing Annual Activity | -15.29 | -43.74 | 130.09 | 0.78 | -6.48 | |
| Net Cash Flow Annual | - | 3.13 | -15.22 | -7.97 | 5.22 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 216.51 | 192.42 | 181.30 | 310.39 | 337.66 | |
| ROE Annual % | 12.91 | 10.59 | 9.75 | 2.51 | 10.37 | |
| ROCE Annual % | 17.17 | 14.17 | 11.94 | 22.12 | 15.05 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.02 | 0.15 | 0.10 | |
| EBDIT Annual Margin % | 14.51 | 13.68 | 12.79 | 13.51 | 12.65 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 175.72 | 165.38 | 155.91 | 147.41 | 143.05 | 121.87 | 135.34 | 122.79 | 125.14 | 119.38 | 116.47 | |
| Operating Expenses Qtr | 149.28 | 141.88 | 133.99 | 127.64 | 124.27 | 105.75 | 116.69 | 106.14 | 108.29 | 104.55 | 102.10 | |
| Operating Profit Qtr | 22.00 | 20.34 | 18.69 | 17.14 | 16.44 | 13.95 | 16.05 | 13.79 | 13.84 | 13.04 | 13.15 | |
| EBIDT Qtr Cr | 26.45 | 23.50 | 21.93 | 19.77 | 18.77 | 16.11 | 18.66 | 16.65 | 16.85 | 14.84 | 14.37 | |
| Depreciation Qtr | 3.54 | 3.39 | 3.33 | 3.19 | 3.57 | 3.13 | 2.90 | 2.76 | 2.90 | 3.15 | 3.08 | |
| Net Profit Qtr | 16.99 | 15.10 | 14.03 | 12.06 | 11.44 | 9.19 | 12.19 | 9.80 | 14.79 | 8.31 | 8.30 | |
| Basic EPS Qtr | 8.17 | 7.26 | 6.75 | 5.79 | 5.37 | 4.23 | 5.59 | 4.50 | 6.97 | 3.81 | 4.11 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 644.42 | 523.05 | 472.64 | 430.69 | 331.34 | |
| Operating Expenses Annual Cr | 552.78 | 452.86 | 413.51 | 372.91 | 287.39 | |
| Operating Profit Annual | 78.17 | 60.23 | 52.42 | 54.69 | 41.47 | |
| Operating Profit Margin Annual % | 12.13 | 11.51 | 11.09 | 12.70 | 12.51 | |
| Total Expenses Annual Cr | 567.33 | 466.01 | 427.07 | 387.17 | 299.20 | |
| EBIDT Annual Cr | 91.64 | 70.19 | 59.13 | 57.78 | 43.95 | |
| EBIDT Annual margin % | 14.22 | 13.42 | 12.51 | 13.42 | 13.27 | |
| Depreciation | 13.44 | 12.36 | 12.15 | 12.96 | 9.29 | |
| PAT Before ExtraOrdinary Items Annual Cr | 58.19 | 42.63 | 38.09 | 15.74 | 23.68 | |
| Net Profit Annual | 58.19 | 42.63 | 38.09 | 15.83 | 16.21 | |
| Basic EPS Annual | 27.88 | 19.70 | 18.58 | 8.70 | 8.90 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 449.94 | 402.27 | 394.78 | 199.12 | 209.66 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 4.52 | 5.46 | 2.25 | 3.58 | 3.54 | |
| Total Current Liabilities Annual Cr | 171.75 | 121.24 | 93.98 | 93.42 | 125.29 | |
| Total Capital Plus Liabilities Annual Cr | 626.21 | 528.98 | 491.01 | 296.12 | 338.49 | |
| Fixed Assets Annual | 184.76 | 124.19 | 99.20 | 95.98 | 70.26 | |
| Total Non Current Assets Annual | 194.92 | 175.44 | 113.46 | 101.81 | 170.46 | |
| Total Current Assets Annual | 431.29 | 353.54 | 377.56 | 194.31 | 168.03 | |
| Total Assets Annual | 626.21 | 528.98 | 491.01 | 296.12 | 338.49 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 14.11 | 3.25 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 108.96 | 60.97 | 9.13 | 11.45 | 25.01 | |
| Cash from Investing Activity Annual | -92.07 | -14.11 | -154.58 | -20.20 | -14.34 | |
| Cash from Financing Annual Activity | -15.29 | -43.74 | 130.09 | 0.78 | -5.44 | |
| Net Cash Flow Annual | - | 3.12 | -15.36 | -7.97 | 5.22 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 216.34 | 192.24 | 181.14 | 310.59 | 327.03 | |
| ROE Annual % | 12.93 | 10.59 | 9.64 | 7.95 | 7.73 | |
| ROCE Annual % | 17.20 | 14.18 | 11.83 | 22.11 | 16.25 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.02 | 0.15 | 0.11 | |
| EBDIT Annual Margin % | 14.52 | 13.68 | 12.69 | 13.51 | 13.36 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Icici Prudential Smallcap Fund | 9.33 | 74504465 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Ashok Kumar Windlass | 21.16 | 74504455 | 0 | 99.07 |
| Vimla Windlass | 1.37 | 74504456 | 0 | 0 |
| Akw Wbl Family Private Trust | 40.3 | 74504462 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Icici Prudential Smallcap Fund | 9.33 | 74504465 |
| Uti - Healthcare Fund | 1.04 | 74504466 |
| Perpetuity Health To Wealth (H2w) Rising Fund | 1.11 | 74504468 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HUF | 0.81 | 74504472 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 05, 2023 | 4 | FINAL | - | Equity Share |
| Sep 09, 2022 | 3.5 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 20, 2024 | Audited Results & Dividend | - |
| Feb 08, 2024 | Quarterly Results | - |
| Nov 08, 2023 | Quarterly Results | - |
| Aug 08, 2023 | Quarterly Results | - |
| May 05, 2023 | Audited Results & Final Dividend | - |
| Feb 08, 2023 | Quarterly Results | - |
| Nov 08, 2022 | Quarterly Results | - |
| Aug 04, 2022 | Quarterly Results | - |
| May 12, 2022 | Audited Results & Dividend | - |
| Feb 02, 2022 | Quarterly Results | - |
| Nov 01, 2021 | Quarterly Results | - |
| Sep 08, 2021 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
02 Jul 2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Clippings
01 Jul 2024
Windlas Biotech Ltd - 543329 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot for re-appointment of Mr. Pawan Kumar Sharma as an executive director w.e.f June 11, 2024 for a period of three years.
25 Jun 2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Subject: Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
10 Jun 2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares pursuant to "Windlas Biotech Limited - Employee Stock Option Plan 2021"
29 May 2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015
29 May 2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015
27 May 2024
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call Transcript Q4 of FY24
21 May 2024
Windlas Biotech Ltd - 543329 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended March 31, 2024
21 May 2024
Windlas Biotech Ltd - 543329 - Recording Of Conference Call
Recording of Conference Call
